Trimetazidine: all 26 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Effect of Trimetazidine on Coronary Flow in Transthyretin Cardiac AmyloidosisNot yet recruitingNCT07836699Phase 2
- Effect of Trimetazidine on Endothelin-1 and Clinical Outcomes of Patients With Diabetic Peripheral NeuropathyRecruitingNCT07794475Phase 1/2
- Allopurinol and Trimetazidine as a Preventive of Acute Kidney Injury in PCI PatientsRecruitingNCT05540184Phase 4
- Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AFCompletedNCT04511520Not applicableResults posted
- The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial HypertensionCompletedNCT03273387Phase 2/3Results posted
- Metoprolol and Trimetazidine for Coronary Heart Disease With AnginaCompletedNCT07074834Not applicable
- Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral NeuropathyCompletedNCT06459193Phase 1/2
- Benefits of Trimetazidine in MASLD PatientsCompletedNCT06140953Phase 2
- The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac AmyloidosisCompletedNCT05633563Phase 4
- Efficacy of Trimetazidine in Diabetic PatientsStatus unknownNCT05556005Phase 2
- The Effects of TMZ on Diabetic NephropathyStatus unknownNCT05147194Phase 2
- Effect of Trimetazidine on Radiotherapy-induced Heart Damage.Status unknownNCT04939857Phase 2/3
- Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT04788745Phase 2
- Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19Status unknownNCT04760821Phase 2
- Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart DiseaseStatus unknownNCT03887013Phase 4
- TRimetazidine for acUte on Chronic Liver Failure STudySuspendedNCT03737448Phase 1
- Trimetazidine in Myocardial Injury After Percutaneous Coronary Intervention in Patients With Angina and DiabetesStatus unknownNCT03715582Phase 3
- Trimetazidine as an Adjunct to Enhance Clopidogrel Response.CompletedNCT03603249Phase 2
- Effect of Trimetazidine on the Improvement of Coronary Microvascular Dysfunction in Patients With INOCA(Ischemia and no Obstructive Coronary Artery Disease)Status unknownNCT03504202Not applicable
- Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT03278444Phase 3
- Treatment of Intermediate-stage Hepatocellular CarcinomaStatus unknownNCT03274427Phase 3
- Effect of Trimetazidine During the Primary PCI on Cardiac Function in Patients With ST-elevation Myocardial InfarctionStatus unknownNCT02826616Not applicable
- The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery DiseaseCompletedNCT02107144Phase 4
- Trimetazidine in Pulmonary Artery HypertensionStatus unknownNCT02102672Phase 2
- Trimetazidine Therapy in Hypertrophic CardiomyopathyStatus unknownNCT01696370Phase 2
- Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart DiseaseCompletedNCT00282360Phase 4